Ligation of CD31 (PECAM-1) on endothelial cells increases adhesive function of αvβ3 integrin and enhances β1 integrin-mediated adhesion of eosinophils to endothelial cells

Blood

Volumn 94, Issue 4, 1999, Pages 1319-1329

  Chiba, Ryuichi ^b   Nakagawa, Noriaki ^b   Kurasawa, Kazuhiro ^b   Tanaka, Yoshiya ^b   Saito, Yasushi ^b   Iwamoto, Itsuo ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; ENDOTHELIUM CELL; EOSINOPHIL; HEMOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

EID: 0033566715     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1319.416k28_1319_1329     Document Type: Article

References (57)

1. Newman PJ, Berndt MC, Gorski J, White GC II, Lyman S, Paddock C, Muller WA: PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219, 1990
2. Muller WA, Ratti CM, McDonnell SL, Cohn ZA: A human endothelial cell-restricted externally disposed plasmalemmal protein enriched in intercellular junction. J Exp Med 170:399, 1989
3. Albelda SM, Oliver PD, Romer LH, Buck CA: EndoCAM: A novel endothelial cell-cell adhesion molecule. J Cell Biol 110:1227, 1990
4. Albelda SM, Muller WA, Buck CA, Newman PJ: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 114:1059, 1991
5. Ohto H, Maeda H, Shibata Y, Chen RF, Ozaki Y, Higashihara M, Takeuchi A, Tohyama H: A novel leukocyte differentiation antigen: Two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. Blood 66:873, 1985
6. Goyert SM, Ferrero EM, Seremetis SV, Winchester RJ, Silver J, Mattison AC: Biochemistry and expression of myelomonocytic antigens. J Immunol 137:3909, 1986
7. Stokiniger H, Gadd SJ, Eher R, Majdic O, Schreiber W, Kasinrerk W, Strass B, Schnabl E, Knapp W: Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 145:3889, 1990
8. -) CD4-positive T cells. Tissue Antigens 38:208, 1991
9. Torimoto Y, Rothstein DM, Dang NH, Schlossman SF, Morimoto C: CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J Immunol 148:388, 1992
10. Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA, Shaw S: CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J Exp Med 176:245, 1992
11. Muller WA, Berman ME, Newman PJ, DeLisser HM, Albelda SM: A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med 175:1401, 1992
12. Cheresh DA: Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 84:6471, 1987
13. Maxfield SR, Moulder K, Koning F, Elbe A, Stingl G, Coligan JE, Shevach EM, Yokoyama WM: Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies. J Exp Med 169:2173, 1989
14. Moulder K, Roberts K, Shevach EM, Coligan JE: The mouse vitronectin receptor is a T cell activation antigen. J Exp Med 173:343, 1991
15. Piali L, Hammel P, Uherek C, Bachmann F, Gisler RH, Dunon D, Imhof BA: CD31/PECAM-1 is a ligand for αvβ3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 130:451, 1995
16. Buckley CD, Doyonnas R, Newton JP, Blystone SD, Brown EJ, Watt SM, Simmons DL: Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sci 109:437, 1996
17. DeLisser HM, Newman PJ, Albelda SM: Molecular and functional aspects of PECAM-1/CD31. Immunol Today 15:490, 1994
18. Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178:449, 1993
19. Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thorn SR, Jones ML, Ward PA, Albelda SM: Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262:1580, 1993
20. Bogen S, Pak J, Garifallou M, Deng X, Muller WA: Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 179:1059, 1994
21. + hemopoietic progenitor cells. J Immunol 153:4673, 1994
22. Berman ME, Muller WA: Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CDl1b/CD18). J Immunol 154:299, 1995
23. Berman ME, Xie Y, Muller WA: Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31 ) in natural killer cell transendothelial migration and β2 integrin activation. J Immunol 156:1515, 1996
24. Yan H-C, Pilewski JM, Zhang O, DeLisser HM, Romer L, Albelda SM: Localization of multiple functional domains on human PECAM-I (CD31) by monoclonal antibody epitope mapping. Cell Adhesion Commun 3:45, 1995
25. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745, 1973
26. Hansel TT, Pound JD, Pilling D, Kitas GD, Salmon M, Gentle TA, Lee SS, Thompson RA: Purification of human eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 122:97, 1989
27. Smith JW, Cheresh DA: Integrin (αvβ3)-ligand interaction. Identification of a heterodimeric RGD binding site on the vitronectin receptor. J Biol Chem 265:2168, 1991
28. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
29. ++ dependent protein kinase. Biochem Biophys Res Commun 135:397, 1986
30. Seynaeve CM, Kazanietz MG, Blumberg PM, Sausville EA, Worland PJ: Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol Pharmacol 45:1207, 1994
31. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y: Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 268:25846, 1993
32. Okada T, Sakuma L, Fukui Y, Hazeki O, Ui M: Blockade of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J Biol Chem 269:3563, 1994
33. Conforti G, Dominguez-Jimenez C, Zanetti A, Gimbrone MA Jr, Cremona O, Marchisio PC, Dejana E: Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood 80:437, 1992
34. Thornhill MH, Kyan-Aung U, Haskard DO: IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. J Immunol 144:3060, 1990
35. Thornhill MH, Haskard DO: IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ J Immunol 145:865, 1990
36. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka KB, Newman W, Luscinskas FW, Gimbrone MA, Mcintyre BW, Bochner BS: IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 148:1086, 1992
37. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577, 1990
38. Dobrina A, Menegazzi R, Carlos TM, Nardon E, Cramer R, Zacchi T, Harlen JM, Patriarca P: Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 88:20, 1991
39. 1 (very late antigen-4) dependent. J Immunol 146:3419, 1991
40. Weller PF, Rand TH, Goelz SE, Chi-Rosso C, Lobb RR: Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88:7430, 1991
41. Bochner BS, Luscinskas FW, Gimbrone MA, Newman W, Sterbinsky SA, Derse-Anthony CP, Klunk D, Schleimer RP: Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: Contributions of endothelial cell adhesion molecules. J Exp Med 173:1553, 1991
42. Piali L, Albelda SM, Baldwin HS, Hammel P, Gisler RH, Imhof BA: Murine platelet endothelial cell adhesion molecule (PECAM-1)/ CD31 modulates β2 integrins on lymphokine-activated killer cells. Eur J Immunol 23:2464, 1993
43. Shimizu Y, van Seventer GA, Ennis E, Newman W, Horgan KJ, Shaw S: Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion. J Exp Med 175:577, 1992
44. Shimizu Y, Mobley JL, Finkelstein LD, Chan ASH: A role for phosphatidylinositol 3-kinase in the regulation of β1 integrin activity by the CD2 antigen. J Cell Biol 131:1867, 1995
45. Kinashi T, Escobedo JA, Williams LT, Takatsu K, Springer TA: Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-γ1 pathways. Blood 86:2086, 1995
46. 3. Curr Opin Cell Biol 9:725, 1997
47. Brooks PC, Montogomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157, 1994
48. Drake CJ, Cheresh DA, Little CD: An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci 108:2655, 1995
49. Sun Q, DeLisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ: Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 271:11090, 1996
50. Prager E, Sunder-Plassmann R, Hansmann C, Koch C, Holter W, Knapp W, Stockinger H: Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J Exp Med 184:41, 1996
51. Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzani U, Stockinger H, Malavasi F: Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 160:395, 1998
52. Ebeling O, Duczmal A, Aigner S, Geiger C, Schollhammer S, Kemshead JT, Moller P, Schwartz-Albiez R, Altevogt P: L1 adhesion molecule on human lymphocytes and monocytes: Expression and involvement in binding to αVβ3 integrin. Eur J Immunol 26:2508, 1996
53. Zhang J, Zhang J, Shattil SJ, Cunninggham MC, Rittenhouse SE: Phosphoinositide 3-kinase γ and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or β-phorbol myristate acetate and roles in promoting the ligand-binding function of αIIbβ3 integrin. J Biol Chem 271:6265, 1996
54. Gleich GJ: The eosinophil and bronchial asthma: Current understanding. J Allergy Clin Immunol 85:422, 1990
55. Bousquet J, Chanez P, Lacoste JY, Bameon G, Ghanavian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB: Eosinophilic inflammation in asthma. N Engl J Med 323:1033, 1990
56. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I: Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 179:1145, 1994
57. Moser R, Fehr J, Bruijnzeel PLB: IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 149:1432, 1992